Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies. [PDF]
du Rand A, Buttle B, Sheppard H.
europepmc +1 more source
Ist die chronische Pankreatitis im Frühstadium mit dem sonographischen Secretintest erfaßbar? [PDF]
Müller-Lissner, S., Riepl, Rudolf L.
core
SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study. [PDF]
Harrs C +6 more
europepmc +1 more source
The Saudi National Policy and Protocol for Epidermolysis Bullosa. [PDF]
Alheggi A +13 more
europepmc +1 more source
Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: A Review of Pathogenesis, Diagnosis and Management. [PDF]
Chandrasekaran A, Moser JC.
europepmc +1 more source
Dystrophic epidermolysis bullosa caused by novel frameshift mutation in the <i>COL7A1</i> gene: A case report. [PDF]
Yang Y, Guan ZW, Li QF.
europepmc +1 more source
Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension. [PDF]
Bageta ML +17 more
europepmc +1 more source
Cross-sectional analysis of wound-associated soluble factors in early, established, and chronic wounds of recessive dystrophic epidermolysis bullosa patients. [PDF]
Alexeev V +7 more
europepmc +1 more source

